“Ligand-gated Ion Channels”的搜索结果

9 个项目

每页

设置降序顺序
  1. HS-10296 hydrochloride

    Catalog No. A21661
    Quick View
    EGFR/T790M inhibitor
    HS-10296 hydrochloride is an orally available and third-Generation inhibitor of epidermal growth factor receptor (EGFR)-activating mutations and T790M-resistant mutation with limited activity against wild-type EGFR. 了解更多
  2. AG-13958

    Catalog No. A21175
    Quick View
    VEGFR inhibitor
    AG-13958 (AG-013958), a potent VEGFR tyrosine kinase inhibitor, is used for treatment of choroidal neovascularization associated with age-related macular degeneration (AMD). 了解更多
  3. Mutant EGFR inhibitor

    Catalog No. A21144
    Quick View
    EGFR inhibitor
    Mutant EGFR inhibitor is a potent and selective mutant EGFR inhibitor extracted from patent WO 2013014448 A1; inhibits EGFRL858R, EGFRExon 19 deletion and EGFRT790M. 了解更多
  4. Canertinib dihydrochloride

    Catalog No. A11344
    Quick View
    EGFR inhibitor
    Canertinib dihydrochloride (CI-1033 dihydrochloride) is a potent and irreversible EGFR inhibitor; inhibits cellular EGFR and ErbB2 autophosphorylation with IC50s of 7.4 and 9 nM. 了解更多
  5. EGFR-IN-2

    Catalog No. A12628
    Quick View
    EGFR inhibitor
    EGFR-IN-2 is a a noncovalent, irreversible, mutant-selective second generation EGFR inhibitor. 了解更多
  6. Mutated EGFR-IN-2

    Catalog No. A18565
    Quick View
    EGFR 抑制剂
    Mutated EGFR-IN-2 (compound 91) is a mutant-selective EGFR inhibitor extracted from patent WO2017036263A1, which potently inhibits single-mutant EGFR (T790M) and double-mutant EGFR (including L858R/T790M (IC50=??1nM) and ex19del/T790M), and can suppress activity of single gain-of-function mutant EGFR (including L858R and ex19del) as well. Mutated EGFR-IN-2 shows anti-tumor antivity. 了解更多
  7. PLX5622

    Catalog No. A18888
    Quick View
    CSF1R inhibitor
    PLX5622 is a highly selective brain penetrant and oral active CSF1R inhibitor with an Ki of 5.9 nM, for extended and specific microglial elimination, preceding and during pathology development. 了解更多
  8. MTX-211

    Catalog No. A18324
    Quick View
    EGFR/PI3K 双重抑制剂
    MTX-211 is a dual inhibitor of EGFR and PI3K, which plays important roles in the progression of KRAS mutant colorectal cancer. MTX-211 has the potential for the treatment of KRAS mutant colorectal cancer. 了解更多
  9. AZD-9291 (Osimertinib)

    Catalog No. A13681
    Quick View
    EGFR 抑制剂
    AZD-9291 (Osimertinib)是第三代EGFR抑制剂,在临床前研究中显示出希望,并为已对现有EGFR抑制剂产生耐药性的晚期肺癌患者提供了希望。 了解更多

9 个项目

每页

设置降序顺序
Rewards